We believe that true, lasting change happens when advanced medicine is combined with expert human care
The approval of injectable semaglutide for adolescents aged 12 and older in 2022 established a precedent for GLP-1-based weight management in younger patients, and an oral option could substantially change the treatment calculus for this population
GLP-1s: Changing the Obesity Treatment Narrative The seismic shift in obesity treatment, propelled by these medications like Wegovy (Semaglutide) and Zepbound (Tirzepatide), has opened up new possibilities
J Epidemiol Glob Health
Common techniques include LC-MS/MS, LC-HRMS, Q-TOF mass spectrometry, Orbitrap mass spectrometry, and ion mobility MS
That increased pressure and prolonged acid exposure cause reflux in 1015% of patients, especially during dose increases